Home > Insider Trading > Filing (0001235802-23-000100)

Filing Details

Accession Number:: 0001235802-23-000100
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-22 16:08:00
Reporting Period:: 2023-08-18

Accepted Time:: 2023-08-22 16:08:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1253176	Vapotherm Inc	VAPO	Surgical & Medical Instruments & Apparatus (3841)	462259298

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1435005	Joseph Army	100 Domain Drive Exeter NH 03833	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-08-18	7,489	$3.07	249,585	No	4	P	Direct
Common Stock	Acquisiton	2023-08-21	27,604	$3.62	277,189	No	4	P	Direct
Common Stock	Acquisiton	2023-08-22	14,907	$3.98	292,096	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	40,625	Indirect	Kimberly D. Army Revocable Trust
Common Stock	62	Indirect	By Spouse

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00 to $3.10, inclusive. The reporting person undertakes to provide to Vapotherm, Inc., any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Includes 1,154 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan, as amended from time to time.
On August 18, 2023, 1-for-8 reverse split of the common stock of Vapotherm, Inc. occurred resulting in a decrease in the number of shares held by the reporting person. In addition, proportionate adjustments have been made to the reporting person's outstanding equity awards, including the number of restricted stock units as reflected on this Form 4. Accordingly, all amounts of securities reported on this Form 4 have been adjusted to reflect the 1-for-8 reverse stock split.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.405 to $3.75, inclusive. The reporting person undertakes to provide to Vapotherm, Inc., any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.915 to $4.00, inclusive. The reporting person undertakes to provide to Vapotherm, Inc., any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (5) to this Form 4.